[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Patrick C. Johnson, MD\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":70},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,43],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":42},"100635506","remote-monitoring-and-symptom-management-digital-application-100635506",false,"NCT07553572","Remote Monitoring and Symptom Management Digital Application","Pilot Randomized Controlled Trial of a Remote Monitoring and Symptom Management Intervention (ASSIST) Among Patients Receiving Systemic Therapy","ASSIST","Inclusion Criteria:\n\n1. Age 18 years or older\n2. Ability to understand English\n3. About to begin definitive systemic treatment (or within 4 weeks of beginning treatment) based upon the oncology treatment intent form for a new diagnosis of breast cancer, colorectal cancer, or lymphoma.\n4. Expected treatment duration of at least 12 weeks\n5. Own or willing to receive a smartphone\n\nExclusion Criteria:\n\n1. Cognitive impairment that would interfere with ability to use smartphone application (as assessed by their attending physician)\n2. Visual or motor impairment that would prevent smartphone use\n3. Expected survival less than 3 months","ALL","18 Years",{"count":20,"type":21},60,"ESTIMATED","INTERVENTIONAL",[24],"NA","The goal of this clinical trial is to learn if an artificial intelligence phone application called ASSIST can help patients receiving cancer treatment.\n\nThe main question\\[s\\] it aims to answer are:\n\nIs ASSIST feasible for patients (meaning can it be used by patients)? Is ASSIST acceptable to patients (meaning do patients like it)?\n\nResearchers will compare the ASSIST phone application to see how it compares to usual clinical care.\n\nParticipants on the ASSIST arm will use the ASSIST phone application for 12 weeks, and participants in both groups will complete surveys.",[27,28,29],"Breast Cancer (Locally Advanced or Metastatic)","Lymphoma","Colorectal Cancer","RECRUITING","2026-04-20",{"date":33,"type":34},"2026-04-28","ACTUAL",{"date":36,"type":34},"2026-04-14",{"date":38,"type":21},"2027-03-31",{"name":40,"class":41},"Patrick C. Johnson, MD","OTHER",1,{"id":44,"slug":45,"hasResults":11,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":49,"eligibilityCriteria":50,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":51,"targetDuration":4,"studyType":22,"phases":53,"briefSummary":54,"conditions":55,"keywords":57,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":62,"lastUpdatePostDateStruct":63,"startDateStruct":65,"completionDateStruct":67,"leadSponsor":69,"locationsCount":42},"100567215","thrive-car-t-digital-app-100567215","NCT06665295","THRIVE-CAR-T Digital App","Randomized Controlled Trial of a Supportive Care Digital Application (THRIVE-CAR-T) for Patients Receiving CAR-T Cell Therapy","THRIVE-CAR-T","Inclusion Criteria:\n\n1. Age 18 years or older\n2. Ability to understand English\n3. Diagnosis of a hematologic malignancy\n4. Receiving autologous CAR-T at MGH with an FDA approved cellular therapy product\n\nExclusion Criteria:\n\n1. Impaired cognition or uncontrolled mental illness that prohibits the ability to provide informed consent based on the oncology clinician assessment\n2. Already participating in another supportive care clinical trial",{"count":52,"type":21},100,[24],"The goal of this clinical trial is to learn if a digital mobile application called THRIVE-CAR-T is helpful for the care of patients undergoing CAR-T cell therapy. The main question\\[s\\] it aims to answer are whether the THRIVE-CAR-T app is feasible and acceptable to patients.",[56],"CAR T-Cell Therapy",[58,59,60,61],"car-t cell therapy","digital application","mobile application","randomized controlled trial","2026-03-26",{"date":64,"type":34},"2026-04-01",{"date":66,"type":34},"2024-10-17",{"date":68,"type":21},"2026-12-31",{"name":40,"class":41},""]